NCT00025194View on ClinicalTrials.gov

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2001

Study Completion Date

July 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

estramustine phosphate sodium

DRUG

ixabepilone

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Center, New York

94115

UCSF Comprehensive Cancer Center, San Francisco

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

48109-0942

University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00025194 - Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | Biotech Hunter | Biotech Hunter